The Mental Cost and Burden of Listening
Launched by UNIVERSITY OF MANCHESTER · Apr 28, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "The Mental Cost and Burden of Listening," is studying how using hearing aids can improve communication for older adults. It aims to find out if hearing aids make it easier to listen, help reduce fatigue when trying to understand speech, and enhance overall wellbeing and sleep quality. The researchers are particularly interested in how cognitive abilities (like memory and thinking) and sleep efficiency play a part in these improvements.
To participate, you need to be 60 years or older, have some degree of hearing loss (specifically, an average loss of 25 decibels or worse), and have never used hearing aids before. If you qualify, you will be part of a randomized controlled trial, meaning you may receive hearing aids to test their effects on your communication and quality of life. This is a chance to see how better hearing could positively impact your daily activities and overall happiness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 60 or older
- • Hearing aid candidate (hearing loss of an average of 25 dB HL or worse)
- • Novice to hearing aids
- Exclusion Criteria:
- • Younger than 60
- • Normal hearing
- • Already uses hearing aids
About University Of Manchester
The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
Patients applied
Trial Officials
Karolina Kluk de-Kort, Doctorate
Study Director
University of Manchester
Antje Heinrich, Doctorate
Study Director
University of Manchester
Josef Schlittenlacher, Doctorate
Study Director
University of Manchester
Stephanie Loukieh, Masters Degree
Principal Investigator
University of Manchester
Raffael Schmitt, Doctorate
Study Director
Sonova AG
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported